Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

PSYCHEDELIC MARKET OVERVIEW

LAST PSYCHEDELICS

Braxia Scientific News Psychedelic

Braxia Scientific CEO Dr. Roger McIntyre to Share Stage With NBA Champion Lamar Odom and ‘Psychedelic Concierge’ Zappy Zapolin to Discuss the Benefits of Ketamine Treatment for Mental Health

October 14, 2021
The Cannabis Stock
News PharmaTher Psychedelic

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

October 13, 2021
The Cannabis Stock
Cybin Inc. News Psychedelic

Cybin Files an International Patent Application Covering Psychedelic Delivery Methods

October 13, 2021
The Cannabis Stock
atai Life Sciences News Psychedelic

atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for Treatment-Resistant Depression (TRD)

October 11, 2021
The Cannabis Stock

LAST CANNABIS

Auxly CAN cannabis News

Auxly Ends Third Quarter 2021 as #6 Licensed Producer in Canada with 6.4% Total National Market Shareⁱ

October 18, 2021
The Cannabis Stock
CAN cannabis News Valens

The Valens Company Announces Entry to Québec Market

October 18, 2021
The Cannabis Stock
CAN cannabis HEXO Corp. News

HEXO Announces Strategic Executive Changes

October 18, 2021
The Cannabis Stock
CAN cannabis News TGod

TGOD Expands Distribution of Highly Dutch Amsterdam Sativa 28g to Ontario

October 16, 2021
The Cannabis Stock